Understanding modern ulcerative colitis through real-world data
Industry trends in ulcerative colitis research: a new path Ulcerative colitis is a chronic...
Industry trends in ulcerative colitis research: a new path Ulcerative colitis is a chronic...
Alzheimer’s disease burden and the current therapy pipeline Alzheimer’s disease remains the leading...
Identifying the gaps in today’s real-world data The 2025 IMPACCT Real-World Evidence Summit brought...
October is Breast Cancer Awareness Month. While pink ribbons and fundraising campaigns help bring...
In a recent webinar, the HealthVerity team including Alexa Woodward, Ph.D., Director of Strategic...
The evolution of heart failure treatment and research Heart failure remains one of the most...
The rise of GLP-1 therapies and the evolution of obesity treatment Over 40% of adults in the U.S....
Turning claims into interoperable evidence More means more. In a world where anyone can make...
Recently, Omada Health and HealthVerity announced a press release highlighting their collaboration...
This is part three of a three-part series on the essential qualities of claims data for life...
Regulatory decision-making depends on evidence that reflects how medical products perform in real-world use, not only in controlled trials. For more than a decade, the Food and Drug Administration has relied on real-world data and real-world evidence...